Sunday - December 22, 2024

Antibodies to Mucin-16 (MUC16), Encoding Polynucleotides and Methods of Treating MUC16-positive Cancer

2024-12-17

ALEXANDRIA, Virginia, Dec. 17 -- EUREKA THERAPEUTICS, INC., Emeryville, California has been assigned a patent (No. US 12168696 B2, initially filed Nov. 14, 2019) developed by four inventors David Spriggs, New York, New York; Javier Morales, Emeryville, California; Yoko Nakano, Emeryville, California; and Hong Liu, Emeryville, California, for "Antibodies to mucin-16 (MUC16), encoding polynucleotides and methods of treating MUC16-positive cancer." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Antibodies to Mucin-16 (MUC16), Encoding Polynucleotides and Methods of Treating MUC16-positive Cancer

Information Request Form

Copyright Targeted News Service 2024